How do filter types of renal replacement therapy affect survival in critically ill patients? Concerns about adsorption of nafamostat mesylate on AN69 membranes
Abstract We are writing to you in response to the article published in BMC Nephrology titled “Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study”. The study provided valuable information on the use of nafamostat mesyl...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-09-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-024-03745-1 |